[ad_1]
Shares of microcap Better Therapeutics Inc.
BTTX,
surged 52% ahead of a conference call scheduled Tuesday morning after the company got Food and Drug Administration approval for a smartphone-based behavioral therapy for those with Type 2 diabetes.
Stock decliners:
Iovance Biotherapeutics stock
IOVA,
slumped 12% as the company planned to sell $150 million in stock.
Shares of Viridian Therapeutics Inc.
VRDN,
fell more than 15% after hours Monday following the biotech drug maker’s announcement it was making changes to its study design for a chronic thyroid eye disease therapy.
ADT Inc.
ADT,
stock dropped more than 4% in the extended session Monday after the home-security and alarm-monitoring company said in a filing that it will have to restate some financial results. ADT found mistakes in the way it dealt with some quarterly impairment losses.
[ad_2]
Source link
